A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that combines four protein biomarkers can detect early-stage pancreatic cancer ...
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Pancreatic cancer is one of the hardest cancers to treat, which makes early detection so crucial, now AI is lending a hand to ...
A new blood test designed to detect early signs of pancreatic cancer is being trialled in the UK. The genomic test analyses blood samples to identify markers of the deadly disease, which often ...
A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced an agreement with the PPD™ clinical research business of Thermo Fisher Scientific to design AIM’s anticipated Phase 3 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results